Physician profile
Raj A Narayan
NPI 1699978163
$2,658.91
in general payments reported to CMS, 2019-2025
15 companies · $958 in 2025
The $958 reported for 2025 was more than what 80% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.00 · 2022: $208 · 2023: $823 · 2024: $657 · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,411 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,410.55 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,538.34 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $291.01 | 2022-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $259.57 | 2023-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Alkermes, INC. | $161.43 | 2019-2025 | Aristada, Lybalvi, Aristada Initio |
| Ironshore Pharmaceuticals INC. | $76.15 | 2023-2024 | Jornay Pm |
| Otsuka America Pharmaceutical, INC. | $57.49 | 2022-2025 | Rexulti, Nuedexta |
| Neurocrine Biosciences, INC. | $54.41 | 2023-2025 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $48.26 | 2025 | Cobenfy |
| Corium, LLC | $37.27 | 2023 | Azstarys |
| Collegium Pharmaceutical, INC. | $32.80 | 2025 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $30.75 | 2025 | Invega Sustenna |
| Axsome Therapeutics, INC. | $21.66 | 2024 | Auvelity |
| Vanda Pharmaceuticals INC. | $20.92 | 2025 | Fanapt, Hetlioz |
| Noven Therapeutics, LLC | $14.99 | 2024 | Xelstrym, Secuado |
| Supernus Pharmaceuticals, INC. | $13.86 | 2024 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Narayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.